Add BrightSurf on Google Email

Vitamin D deficiency leads to dementia

A world-first study from the University of South Australia found a direct link between vitamin D deficiency and increased risk of dementia and stroke. The study analyzed data from 294,514 participants and found that up to 17% of dementia cases might have been avoided by boosting vitamin D levels.

SourceUniversity of South Australia·JournalAmerican Journal of Clinical Nutrition·TypeData/statistical analysis·DateJun 13, 2022

New research gives insights into how organelles divide in cells

Scientists have identified a new pathway for peroxisome division, independent of Mitochondrial Fission Factor (MFF). The study, led by Professor Michael Schrader, reveals that PEX11β and FIS1 cooperate to divide peroxisomes, restoring normal morphology. This discovery offers potential therapeutic options for diseases caused by defects ...

SourceUniversity of Exeter·JournalJournal of Cell Science·TypeExperimental study·DateJun 9, 2022

Genetic roots of 3 mitochondrial diseases ID’d via new approach

Researchers have identified the genetic causes of three mitochondrial diseases and proposed 20 additional possibilities for further investigation using a new approach. The study provides a platform to better understand how mitochondria's hundreds of proteins work together, which could lead to improved diagnoses and treatments.

SourceWashU Medicine·JournalNature·TypeExperimental study·DateMay 25, 2022

Genetic test can diagnose certain immune system disorders

Researchers developed a genetic test that diagnoses primary immunodeficiency disorders (PID), revealing inherited genetic defects in nearly half of patients. The test uses next-generation sequencing technology to identify specific gene variants associated with PID, enabling targeted treatment and earlier intervention for family members.

SourceElsevier·JournalJournal of Molecular Diagnostics·TypeExperimental study·DateMay 23, 2022

Flip-flop genome

Inversions in the human genome are more common than previously believed, according to a recent study. The researchers found that these genetic variations can lead to genomic instability and an increased risk of certain diseases, including developmental delays and neuropsychiatric disorders.

A new era of mitochondrial genome editing has begun

Scientists have successfully developed a gene-editing platform called TALED that can perform A-to-G base conversion in mitochondria, the final missing piece of the puzzle in gene-editing technology. This breakthrough has significant implications for treating previously incurable genetic diseases caused by mutations in mitochondrial DNA.

SourceInstitute for Basic Science·JournalCell·TypeExperimental study·DateApr 25, 2022

The recovery process after a heart attack

A recent study published in Molecular Therapy Nucleic Acids found that the molecule urocortin-2 may regulate recovery processes after a heart attack by modulating miR-29a. Treatment with urocortin-2 could favor patient recovery by regulating apoptosis and fibrosis.

SourceUniversity of Seville·JournalMolecular Therapy — Nucleic Acids·DateApr 5, 2022

First complete human genome poised to strengthen genetic analysis, NIST study shows

The T2T consortium's completed human genome has shown significant improvements in DNA sequencing accuracy, correcting tens of thousands of errors and revealing millions of genetic variations. This new reference genome can support the analysis of over 200 genes of medical relevance, potentially propelling research into genetic disorders.

Huntington's disease: Astrocytes to the rescue!

A recent study found that stimulating reactive astrocytes promotes the elimination of toxic protein aggregates in Huntington's disease. This cooperative mechanism between neurons and astrocytes holds promise for potential treatments.

SourceCNRS·JournalBrain·TypeExperimental study·DateMar 18, 2022

March issues of American Psychiatric Association Journals cover genomics and mental illnesses and associations between recent public health crises with traumatic stress

The March issues of American Psychiatric Association journals focus on the genomics of psychopathology, exploring its relationship with various mental illnesses. Research highlights unique genetic patterns among individuals who die by suicide using violent means.

SourceAmerican Psychiatric Association·JournalAmerican Journal of Psychiatry·DateMar 3, 2022

New methods for network visualizations enable change of perspectives and views

Researchers developed a new method for generating network layouts that allow for visualizing different information in two- and three-dimensional virtual space. This facilitates the exploration of complex protein interactions and provides more versatile, comprehensible representations of networks.

Facial analysis improves diagnosis

Researchers developed an AI system called GestaltMatcher that uses facial characteristics to detect rare diseases with high accuracy. The system considers similarities between patients and can even suggest diagnoses for previously unknown diseases.

SourceUniversity of Bonn·JournalNature Genetics·DateFeb 10, 2022

Insight into the genetics of autism offers hope for new drug treatments

Researchers at Lancaster University have identified a genetic change that impacts insulin signaling and glucose metabolism in the brain, which may lead to effective drug treatments for autism. The study found that individuals with a specific DNA deletion are more likely to develop neurodevelopmental disorders, including autism.

SourceLancaster University·JournalAutism Research·TypeData/statistical analysis·DateFeb 10, 2022

New benchmark could improve detection of genetic variants linked to spinal muscular atrophy, other diseases

A new DNA benchmark, developed by NIST and collaborators, enables more accurate detection of genetic variants linked to diseases such as spinal muscular atrophy. The benchmark, based on HiFi sequencing technology, helps labs and clinics sequence genes with high accuracy, critical for disease diagnosis and treatment.

ADHD medicine may treat symptoms of genetic movement disorder in children, University of Maryland School of Medicine study finds

A University of Maryland School of Medicine study finds that a common ADHD medication, lisdexamfetamine, reduces symptoms of a rare genetic movement disorder in children, including collapsing episodes and improvements in speech and concentration. The treatment may also shed light on the mechanisms behind other neuromuscular diseases.

SourceUniversity of Maryland School of Medicine·JournalMovement Disorders Clinical Practice·TypeExperimental study·DateFeb 2, 2022

Gene-environment interactions that drives autism

Gene-environment interactions play a crucial role in the development of autism symptoms, according to a new study by UNIGE researchers. By inhibiting Trpv4 and inducing massive inflammation, scientists observed neuronal hyperexcitability, which disrupted communication channels and led to social avoidance behaviors.

SourceUniversité de Genève·JournalMolecular Psychiatry·TypeNews article·DateJan 31, 2022

New test to screen newborns for rare genetic disorders paves the way for earlier diagnosis and treatment

A new test has been developed to screen for three rare genetic disorders - Prader Willi, Angelman, and Dup15q syndromes - in newborns. The test uses Methylation Specific-Quantitative Melt Analysis (MS-QMA) and showed high accuracy in distinguishing between those with the disorders and those without.

SourceMurdoch Childrens Research Institute·JournalJAMA·TypeRandomized controlled/clinical trial·DateJan 24, 2022